2-106415971-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001144013.2(RGPD3):c.4943C>T(p.Ala1648Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,611,596 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000540 AC: 82AN: 151856Hom.: 1 Cov.: 25 show subpopulations
GnomAD2 exomes AF: 0.0000376 AC: 9AN: 239650 AF XY: 0.0000385 show subpopulations
GnomAD4 exome AF: 0.0000644 AC: 94AN: 1459622Hom.: 0 Cov.: 35 AF XY: 0.0000578 AC XY: 42AN XY: 726120 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.000546 AC: 83AN: 151974Hom.: 1 Cov.: 25 AF XY: 0.000579 AC XY: 43AN XY: 74268 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.4943C>T (p.A1648V) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a C to T substitution at nucleotide position 4943, causing the alanine (A) at amino acid position 1648 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at